Lipigon Pharmaceuticals Valuation Multiples

Lipigon Pharmaceuticals Overview

About Lipigon Pharmaceuticals

Lipigon Pharmaceuticals AB develops medicines for diseases caused by disorders of the body's handling of fats. It focuses on orphan drugs for unusual diseases where there is no adequate treatment.

Founded

2010

HQ

Employees

6

Website

lipigon.se

Sectors

BiopharmaceuticalsBioTech

Financials (FY)

Revenue: $1M

EBITDA: ($3M)

Market Cap

$291K

Valuation Multiples

Multiples.vc

Start free trial

Lipigon Pharmaceuticals Financials

Lipigon Pharmaceuticals reported last fiscal year revenue of $1M and negative EBITDA of ($3M).

In the same fiscal year, Lipigon Pharmaceuticals generated ($3M) in EBITDA losses and had net loss of ($3M).

Lipigon Pharmaceuticals P&L

In the most recent fiscal year, Lipigon Pharmaceuticals reported revenue of $1M and EBITDA of ($3M).

Lipigon Pharmaceuticals expects next 12-month revenue of XXX and NTM EBITDA of XXX

Lipigon Pharmaceuticals Stock Performance

Lipigon Pharmaceuticals has current market cap of $291K.

Lipigon Pharmaceuticals' stock price is $0.00.

Lipigon Pharmaceuticals Valuation Multiples

Lipigon Pharmaceuticals trades at (1.4x) EV/Revenue multiple, and 0.6x EV/EBITDA.

Lipigon Pharmaceuticals Financial Valuation Multiples

As of April 19, 2026, Lipigon Pharmaceuticals has market cap of $291K.

Equity research analysts estimate Lipigon Pharmaceuticals' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Lipigon Pharmaceuticals has a P/E ratio of (0.1x).

Lipigon Pharmaceuticals Margins & Growth Rates

Lipigon Pharmaceuticals' revenue in the last fiscal year declined by (37%).

Lipigon Pharmaceuticals' revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.7M for the same period.

Lipigon Pharmaceuticals Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

Lipigon Pharmaceuticals M&A Activity

Lipigon Pharmaceuticals acquired XXX companies to date.

Last acquisition by Lipigon Pharmaceuticals was on XXXXXXXX, XXXXX. Lipigon Pharmaceuticals acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

Lipigon Pharmaceuticals Investment Activity

Lipigon Pharmaceuticals invested in XXX companies to date.

Lipigon Pharmaceuticals made its latest investment on XXXXXXXX, XXXXX. Lipigon Pharmaceuticals invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).